[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [Regeneron Pharmaceuticals Inc](/topic/regeneron-pharmaceuticals-inc) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$FOXO 🧐 #StockMarket #NASDAQ #NYSE #Stocks #GlobalTrade #StocksInNews #healthcare #AI #investors #Bullish #Biotechnology #Technology #HODL $XLV #MYNZ $HCA $UHS $BIIB $ISRG $BSX $DHR $UNH $JNJ $MCK $ABBV $REGN $ELV $VRTX $AZN $A $MYNZ $BCTX $QQQ $SPY $NVDA" [X Link](https://x.com/Charlie35911/status/1980429031955722562) [@Charlie35911](/creator/x/Charlie35911) 2025-10-21T00:20Z 3187 followers, XXX engagements "Everyone thank you for your patience. The time for $XBI has finally come. @FDA please announce the 2nd round of CNPV soon. $QURE is ready to soar just like $SNY $REGN $RVMD $IRON and $ACHV. Qure is on track to become a blockbuster emerging company worth 610b within a year" [X Link](https://x.com/Ssunten_/status/1980424825878561141) [@Ssunten_](/creator/x/Ssunten_) 2025-10-21T00:04Z XXX followers, 2215 engagements "$RVMD Mizuho analyst Joseph Catanzaro initiated coverage of Revolution Medicines with an Outperform rating and $XX price target. The firm believes the company's portfolio of RAS(ON) inhibitors are positioned to play "significant roles" in pancreatic ductal adenocarcinoma non-small cell lung cancer and colorectal cancer. Daraxonrasib in PDAC alone can drive "meaningful upside" in the shares the analyst tells investors in a research note. Mizuho believes Revolution's portfolio could generate $10B in risk-adjusted sales in 2035" [X Link](https://x.com/zohmbastic/status/1980369095733154119) [@zohmbastic](/creator/x/zohmbastic) 2025-10-20T20:22Z 9080 followers, 1959 engagements "Many are starting to catch onto the Biotech theme Ive been talking about & I think its just getting started. I broke down the full setup & shared the names I believe are poised to run in my write-up last weekend. ETFs: $XBI $IBB Stocks: $CRSP $GILD $NTLA $REGN $TWST $VRTX" [X Link](https://x.com/StonkChris/status/1980058125194395750) [@StonkChris](/creator/x/StonkChris) 2025-10-19T23:46Z 24.1K followers, 19.5K engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$FOXO 🧐 #StockMarket #NASDAQ #NYSE #Stocks #GlobalTrade #StocksInNews #healthcare #AI #investors #Bullish #Biotechnology #Technology #HODL $XLV #MYNZ $HCA $UHS $BIIB $ISRG $BSX $DHR $UNH $JNJ $MCK $ABBV $REGN $ELV $VRTX $AZN $A $MYNZ $BCTX $QQQ $SPY $NVDA"
X Link @Charlie35911 2025-10-21T00:20Z 3187 followers, XXX engagements
"Everyone thank you for your patience. The time for $XBI has finally come. @FDA please announce the 2nd round of CNPV soon. $QURE is ready to soar just like $SNY $REGN $RVMD $IRON and $ACHV. Qure is on track to become a blockbuster emerging company worth 610b within a year"
X Link @Ssunten_ 2025-10-21T00:04Z XXX followers, 2215 engagements
"$RVMD Mizuho analyst Joseph Catanzaro initiated coverage of Revolution Medicines with an Outperform rating and $XX price target. The firm believes the company's portfolio of RAS(ON) inhibitors are positioned to play "significant roles" in pancreatic ductal adenocarcinoma non-small cell lung cancer and colorectal cancer. Daraxonrasib in PDAC alone can drive "meaningful upside" in the shares the analyst tells investors in a research note. Mizuho believes Revolution's portfolio could generate $10B in risk-adjusted sales in 2035"
X Link @zohmbastic 2025-10-20T20:22Z 9080 followers, 1959 engagements
"Many are starting to catch onto the Biotech theme Ive been talking about & I think its just getting started. I broke down the full setup & shared the names I believe are poised to run in my write-up last weekend. ETFs: $XBI $IBB Stocks: $CRSP $GILD $NTLA $REGN $TWST $VRTX"
X Link @StonkChris 2025-10-19T23:46Z 24.1K followers, 19.5K engagements
/topic/regeneron-pharmaceuticals-inc/posts